This federal contract award to Roche Diagnostics Corporation, valued at $16,777.40, is for the supply of COVID-19 reagents and Cobas laboratory equipment and supplies to the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 4. The contract, awarded on September 1, 2024, is a firm-fixed price delivery order with a completion date of September 30, 2024. Roche Diagnostics is a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and...
The Department of Veterans Affairs (VA) awarded a $132,686.76 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, which was not set aside, was issued under the VA's Veterans Integrated Service Network 12 and will provide molecular pathology services to support the VA's COVID-19 response efforts. Roche Diagnostics has a history of supplying critical medical equipment,...
Roche Diagnostics Corporation has been awarded an $886,325 fixed-price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide COVID-19 reagents and consumables. Under this contract, Roche will supply test kits, reagents, and related materials to support the VA's coronavirus diagnostic testing efforts through December 2021. The contract was awarded using Coronavirus COVID-19 national interest funding to address the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $939,883 firm fixed price definitive contract to Roche Diagnostics Corporation. The contract is for COVID reagents to support Roche Cobas systems and will provide reagents through December 2021 to assist VA-VHA with coronavirus testing. As the prime, Roche Diagnostics will deliver the requested products from their Castleton, Indiana location to aid VA medical centers in serving...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $133,694.18 firm fixed-price purchase order to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for the delivery of reagents to support the VA's healthcare services for veterans, with a performance period ending on November 4, 2022. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated...
The U.S. Department of Veterans Affairs (VA) awarded a $194,833.19 firm-fixed-price delivery order contract to Roche Diagnostics Corporation for the provision of reagents. This contract has an ultimate completion date of October 15, 2026. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a set-aside designation. Roche Diagnostics has previously received awards from the...
The U.S. Department of Veterans Affairs (VA) awarded a one-year delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and consumables. The $140,048.65 firm-fixed-price contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This delivery order is placed against Roche's Indefinite Delivery...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA) awarded Roche Diagnostics Corporation a $438,061.37 delivery order against its Critical Analyzers, Laboratory (FSS-66-III) master contract for Roche 6800 COVID LV REAGENTS. The contract has a period of performance from December 10, 2021 through December 9, 2022 and utilizes a firm fixed price pricing structure. The place of performance will be Castleton, Indiana. Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order valued at $241,658.80 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of COBAS reagents. The contract has a completion date of September 30, 2023 and does not have a set-aside designation. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics, has provided a wide range of laboratory instruments, reagents, test...
This federal contract award is to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $337,097.55 firm-fixed-price purchase order to Roche Diagnostics for the lease of ROCHE COBAS 6800 and the provision of COVID-19 reagents and...